Auto-antibodies and cancer in systemic sclerosis

Autoimmunity Reviews

Volumn 16, Issue 8, 2017, Pages 883-884

  Boonstra, Maaike ^a   Huizinga, Tom W J ^a   de Vries Bouwstra, Jeska K ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Anti Pm Scl antibodies; Auto antibodies; Cancer; Systemic sclerosis

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; PM ANTIBODY; RNAPIII ANTIBODY; SCL ANTIBODY; THTO ANTIBODY; TOPOISOMERASE ANTIBODY; U1RNP ANTIBODY; U3RNP ANTIBODY; UNCLASSIFIED DRUG; ANTIBODY;

ANTIBODY SCREENING; CANCER PATIENT; CANCER SCREENING; HUMAN; LETTER; MALIGNANT NEOPLASM; SYSTEMIC SCLEROSIS; LOCALIZED SCLERODERMA; NEOPLASM; RISK FACTOR;

ANTIBODIES; HUMANS; NEOPLASMS; RISK FACTORS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC;

EID: 85020117714     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2017.05.023     Document Type: Letter

References (8)

1. Bernal-Bello, D., de Tena, J.G., Guillén-del Castillo, A., Selva-O'Callaghan, A., Callejas-Moraga, E.L., Marín-Sánchez, A.M., et al. Novel risk factors related to cancer in scleroderma. Autoimmun Rev 16 (2017), 461–468.
2. Meijs, J., Schouffoer, A.A., Ajmone Marsan, N., Kroft, L.J., Stijnen, T., Ninaber, M.K., et al. Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis. RMD open, 2(1), 2016, e000159.
3. Joseph, C.G., Darrah, E., Shah, A.A., Skora, A.D., Casciola-Rosen, L.A., Wigley, F.M., et al. Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science 343:6167 (2014), 152–157.
4. Husain, I., Mohler, J.L., Seigler, H.F., Besterman, J.M., Elevation of topoisomerase I messenger RNA, protein, and catalytic activity in human tumors: demonstration of tumor-type specificity and implications for cancer chemotherapy. Cancer Res 54:2 (1994), 539–546.
5. Zhang, W., Mao, J.-H., Zhu, W., Jain, A.K., Liu, K., Brown, J.B., et al. Centromere and kinetochore gene misexpression predicts cancer patient survival and response to radiotherapy and chemotherapy. Nat Commun, 7, 2016.
6. Marshall, L., White, R.J., Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer 8:12 (2008), 911–914.
7. Olesen, A.B., Svaerke, C., Farkas, D., Sørensen, H.T., Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study. Br J Dermatol 163:4 (2010), 800–806.
8. Onishi, A., Sugiyama, D., Kumagai, S., Morinobu, A., Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies. Arthritis Rheum 65:7 (2013), 1913–1921.